Novavax "Can Produce Omicron Vaccine Next Month"

Vaccine and syringe placed in front of the Novavax logo

American pharmaceutical company Novavax announced that it will be able to produce a vaccine targeting the new COVID-19 variant Omicron starting next month.

According to major foreign media on the 2nd (local time), Novavax stated regarding the commercial production of the Omicron-specific vaccine, "We have begun developing the Omicron-specific spike protein antigen and will start laboratory testing of the new vaccine within a few weeks."

Novavax is also experimenting with a 'two-track' strategy to determine whether the existing COVID-19 vaccine is effective against the Omicron variant.

Novavax had previously announced on the 26th of last month (local time) that it had started developing a vaccine for the Omicron variant.

Other vaccine manufacturers such as Moderna and Pfizer-BioNTech have also begun developing vaccines to respond to the Omicron variant.